[go: up one dir, main page]

AR050101A1 - Oxazolidinonas que contienen oxindoles como agentes antibacterianos. - Google Patents

Oxazolidinonas que contienen oxindoles como agentes antibacterianos.

Info

Publication number
AR050101A1
AR050101A1 ARP050103255A ARP050103255A AR050101A1 AR 050101 A1 AR050101 A1 AR 050101A1 AR P050103255 A ARP050103255 A AR P050103255A AR P050103255 A ARP050103255 A AR P050103255A AR 050101 A1 AR050101 A1 AR 050101A1
Authority
AR
Argentina
Prior art keywords
antibacterial agents
oxindols
oxazolidinones
oxazolidinones containing
oxindoles
Prior art date
Application number
ARP050103255A
Other languages
English (en)
Original Assignee
Pharmacia & Upjohn Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35079333&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR050101(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc
Publication of AR050101A1 publication Critical patent/AR050101A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La presente se refiere a oxazolidinonas que contienen oxindoles como agentes antibacterianos, composiciones farmacéuticas que los contienen y usos para tratar infecciones bacterianas. Reivindicacion 1: Un compuesto de formula (1) o una sal farmacéuticamente aceptable del mismo en la que Y1 es -CH- o -CF-; R1 es -alquilo (C1-4), sustituido opcionalmente con un átomo de fluoro, o R1 es -cicloalquilo (C3-5); y R2 es -H o -CH3.
ARP050103255A 2004-08-06 2005-08-04 Oxazolidinonas que contienen oxindoles como agentes antibacterianos. AR050101A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US59982204P 2004-08-06 2004-08-06

Publications (1)

Publication Number Publication Date
AR050101A1 true AR050101A1 (es) 2006-09-27

Family

ID=35079333

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050103255A AR050101A1 (es) 2004-08-06 2005-08-04 Oxazolidinonas que contienen oxindoles como agentes antibacterianos.

Country Status (24)

Country Link
US (2) US20080262056A1 (es)
EP (2) EP1781642A1 (es)
JP (2) JP2008509125A (es)
CN (1) CN101001853A (es)
AP (1) AP2007003904A0 (es)
AR (1) AR050101A1 (es)
AU (1) AU2005270951A1 (es)
BR (2) BRPI0514020A (es)
CA (2) CA2576041A1 (es)
EA (1) EA200700322A1 (es)
GT (1) GT200500204A (es)
IL (1) IL180957A0 (es)
MA (1) MA28793B1 (es)
MX (2) MX2007001568A (es)
NL (1) NL1029686C2 (es)
NO (1) NO20071230L (es)
PA (1) PA8640901A1 (es)
PE (1) PE20060351A1 (es)
SV (1) SV2006002180A (es)
TN (1) TNSN07043A1 (es)
TW (1) TWI289448B (es)
UY (1) UY29048A1 (es)
WO (2) WO2006016221A1 (es)
ZA (1) ZA200700476B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006231919A1 (en) * 2005-04-06 2006-10-12 Pharmacia & Upjohn Company Llc 7-fluoro-1,3-dihydro-indol-2-one oxazolidinones as antibacterial agents
EP1869029A1 (en) * 2005-04-06 2007-12-26 Pharmacia & Upjohn Company LLC An oxindole oxazolidinone as antibacterial agent
CN103420995B (zh) * 2013-09-07 2015-07-01 吉首大学 噁唑烷酮-烷胺基-呋喃酮型化合物及其制法和用途
CN103483329B (zh) * 2013-09-07 2015-08-05 吉首大学 呋喃酮-芳基-噁唑烷酮型化合物及其制法和用途
CN111018840B (zh) * 2017-10-25 2022-09-09 西南大学 3-咪唑取代的靛红唑醇类化合物及其制备方法和医药应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164510A (en) * 1988-09-15 1992-11-17 The Upjohn Company 5'Indolinyl-5β-amidomethyloxazolidin-2-ones
JP2865211B2 (ja) * 1988-09-15 1999-03-08 ファルマシア・アンド・アップジョン・カンパニー ５’―インドリニル―５β―アミドメチルオキサゾリジン―２―オン類、３―（縮合環置換）フェニル―５β―アミドメチルオキサゾリジン―２―オン類および３―（窒素原子置換）フェニル―５β―アミドメチルオキサゾリジン―２―オン類
DE4425612A1 (de) * 1994-07-20 1996-04-04 Bayer Ag 6-gliedrige stickstoffhaltige Heteroaryl-oxazolidinone
CN1046520C (zh) * 1994-11-15 1999-11-17 法玛西雅厄普约翰美国公司 二环噁嗪及噻嗪噁唑烷酮抗菌剂
HRP960159A2 (en) * 1995-04-21 1997-08-31 Bayer Ag Benzocyclopentane oxazolidinones containing heteroatoms
AU716493B2 (en) * 1995-09-01 2000-02-24 Pharmacia & Upjohn Company Phenyloxazolidinones having a C-C bond to 4-8 membered heterocyclic rings
DE19601265A1 (de) * 1996-01-16 1997-07-17 Bayer Ag 2-Oxo- und 2-Thio-1,2-dihydrochinolinyl-oxazolidinone
DE19601627A1 (de) * 1996-01-18 1997-07-24 Bayer Ag Heteroatomhaltige Cyclopentanopyridyl-Oxazolidinone
GB9601666D0 (en) * 1996-01-27 1996-03-27 Zeneca Ltd Chemical compounds
GB9702213D0 (en) * 1996-02-24 1997-03-26 Zeneca Ltd Chemical compounds
GB9609919D0 (en) * 1996-05-11 1996-07-17 Zeneca Ltd Chemical compounds
US5990136A (en) * 1996-08-21 1999-11-23 Pharmacia & Upjohn Company Isoxazoline derivatives useful as antimicrobials
GB9717804D0 (en) * 1997-08-22 1997-10-29 Zeneca Ltd Chemical compounds
NZ505902A (en) * 1998-01-23 2003-08-29 Upjohn Co Oxazolidinone compounds useful as antimicrobial agents and combinatorial libraries
GB9812019D0 (en) * 1998-06-05 1998-07-29 Zeneca Ltd Chemical compounds
DE60001807T2 (de) * 1999-02-01 2003-11-06 Pharmacia & Upjohn Co., Kalamazoo VERFAHREN ZU HERSTELLUNG VON o-FLUORIERTEN TETRAHYDROTHIOPYRAN CARBAMATEN
ATE246189T1 (de) * 1999-05-27 2003-08-15 Upjohn Co Bizyklische oxazolidinone als antibakterielle mittel
AR038536A1 (es) * 2002-02-25 2005-01-19 Upjohn Co N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
US7012088B2 (en) * 2003-02-24 2006-03-14 Pharmacia & Upjohn Company Indolone oxazolidinones and derivatives thereof
AU2006231919A1 (en) * 2005-04-06 2006-10-12 Pharmacia & Upjohn Company Llc 7-fluoro-1,3-dihydro-indol-2-one oxazolidinones as antibacterial agents

Also Published As

Publication number Publication date
CA2576041A1 (en) 2006-02-16
EA200700322A1 (ru) 2007-08-31
CN101001853A (zh) 2007-07-18
PE20060351A1 (es) 2006-05-03
ZA200700476B (en) 2008-10-29
MA28793B1 (fr) 2007-08-01
IL180957A0 (en) 2007-07-04
NL1029686A1 (nl) 2006-02-07
UY29048A1 (es) 2006-03-31
NO20071230L (no) 2007-05-04
BRPI0514020A (pt) 2008-05-27
WO2006016220A1 (en) 2006-02-16
TNSN07043A1 (fr) 2008-06-02
SV2006002180A (es) 2006-06-26
JP2008509126A (ja) 2008-03-27
MX2007001526A (es) 2007-03-27
EP1781642A1 (en) 2007-05-09
MX2007001568A (es) 2007-04-16
TW200612924A (en) 2006-05-01
CA2575702A1 (en) 2006-02-16
BRPI0513083A (pt) 2008-04-22
TWI289448B (en) 2007-11-11
NL1029686C2 (nl) 2006-07-18
US20080262056A1 (en) 2008-10-23
WO2006016221A1 (en) 2006-02-16
AU2005270951A1 (en) 2006-02-16
US20060030609A1 (en) 2006-02-09
JP2008509125A (ja) 2008-03-27
EP1781643A1 (en) 2007-05-09
AP2007003904A0 (en) 2007-02-28
GT200500204A (es) 2006-03-02
PA8640901A1 (es) 2007-01-17

Similar Documents

Publication Publication Date Title
AR072261A1 (es) Derivados piperazin-pirazolicos, composiciones farmaceuticas que los contienen y usos de los mismos como agentes anticancerigenos.
ECSP12011880A (es) INHIBIDORES DE N1-PIRAZOLOESPIROCETONA ACETIL-CoA CARBOXILASA
AR047076A1 (es) Compuestos de pirrolotriazina como inhibidores de tirosina quinasas, composiciones farmaceuticas
CR11470A (es) Compuestos organicos
GT200600518A (es) Derivados de pirimidina
PE20201256A1 (es) Compuestos monobactamicos cromanos para el tratamiento de infecciones bacterianas
MX343264B (es) Ciertas amino-piridazinas, composiciones de las mismas y metodos de uso de los mismos.
AR083849A1 (es) Antagonistas de mdm2 de espiro-oxindol
ECSP10010223A (es) Derivados de aminobenzamida como agentes útiles para el control de parásitos de animales
CL2013002417A1 (es) Compuestos derivados de fluoropiridinona; composición farmacéutica que los comprende; y su uso en el tratamiento de infecciones bacterianas.
AR039936A1 (es) Formulacion farmaceutica de liberacion modificada
CL2008003326A1 (es) Compuestos derivados de [(2r)-3-[2-(5-fluoro-4-pirimidinil)hidrazino]-3-oxopropil]hidroxiformamida, formas polimorficas 1, 2 y 3 de dichos compuestos; composicion farmaceutica; y su uso en el tratamiento de una enfermedad bacteriana del oido, sinusitis, infeccion del tracto respiratorio superior, entre otras.
CR11208A (es) Derivados de pirimidina utiles para el tratamiento de condiciones inflamatorias o alergicas
AR062737A1 (es) Composicion farmaceutica que comprende un compuesto derivado de aril-azabiciclo, compuesto correspondiente y su uso para la preparacion de un medicamento
PE20210478A1 (es) Compuestos heteroaromaticos como inhibidores de vanina
PE20200333A1 (es) Compuestos y metodos para tratar infecciones bacterianas
AR039727A1 (es) Difluorotioacetamidas de oxazolidinonas como agentes antibacterianos y composicion farmaceutica en base a ellas
AR077429A1 (es) Compuestos hidroxiasenapina sus derivados y composiciones farmaceuticas que comprenden los mismos
AR050101A1 (es) Oxazolidinonas que contienen oxindoles como agentes antibacterianos.
AR039475A1 (es) 6-alquiliden-penems triciclicos como inhibidores de beta-lactamasa
ECSP22027287A (es) Derivados de 2-azaspiro[3,4]octano como agonistas de m4
CO2019004547A2 (es) Derivado de urea
AR054888A1 (es) Derivados de quinolina como agentes antibacterianos
CR9417A (es) 7-fluoro-1,3-dihidro-indol-2-ona oxazolidinonas como agentes antibacteriales
AR083780A1 (es) Composicion farmaceutica para tratar infecciones del hcv

Legal Events

Date Code Title Description
FB Suspension of granting procedure